{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:25:24Z","timestamp":1792218324471,"version":"4.4.0"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Modern osteoporosis treatment began in the mid-1990s with the approval of amino-bisphosphonates, anti-resorptive agents that have been shown to decrease osteoporotic fracture risk by about half. In 2005, the first cases of atypical femoral fractures (AFF), occurring in the shaft of the femur, were reported. Since then, more cases have been found, leading to great concern among patients and a dramatic decrease in bisphosphonate prescribing. The pathogenesis and incidence of AFF are reviewed herein. Management and an approach to prevention or early detection of AFF are also provided. Denosumab, a more recently approved anti-resorptive medication has also been associated with AFF. Long-term management of osteoporosis and prevention of fracture are challenging in light of this serious but uncommon side effect, yet with an aging population osteoporotic fracture is destined to increase in frequency.<\/jats:p>","DOI":"10.1530\/eje-17-1002","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T01:25:53Z","timestamp":1516152353000},"page":"R81-R87","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":34,"title":["MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy"],"prefix":"10.1093","volume":"178","author":[{"given":"Robert A","family":"Adler","sequence":"first","affiliation":[{"name":"Endocrinology and Metabolism Section, McGuire Veterans Affairs Medical Center, Division of Endocrinology,Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"ref301","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","year":"2017","journal-title":"Archives of Osteoporosis"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2106\/JBJS.N.00075","article-title":"Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry","volume":"96","year":"2014","journal-title":"Journal of Bone and Joint Surgery American Volume"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00198-015-3396-3","article-title":"Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy","volume":"27","year":"2016","journal-title":"Osteoporosis International"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bone.2010.12.033","article-title":"Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features","volume":"48","year":"2011","journal-title":"Bone"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00198-012-2173-9","article-title":"Atypical fractures do not have a thicker cortex","volume":"23","year":"2012","journal-title":"Osteoporosis International"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bone.2012.10.006","article-title":"Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy","volume":"52","year":"2013","journal-title":"Bone"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","article-title":"Cost-effective osteoporosis treatment thresholds: the United States perspective","volume":"19","year":"2008","journal-title":"Osteoporosis International"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","year":"2016","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/RHU.0000000000000170","article-title":"Bisphosphonates and hip and nontraumatic subtrochanteric femoral fractures in the Veterans Health Administration","volume":"20","year":"2014","journal-title":"Journal of Clinical Rheumatology"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Postmenopausal osteoporosis","volume":"374","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00198-015-3396-3","article-title":"Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy","volume":"27","year":"2016","journal-title":"Osteoporosis International"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","year":"2014","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref351","first-page":"1","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2013 2016","volume":"22","year":"2016","journal-title":"Endocrine Practice"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Postmenopausal osteoporosis","volume":"374","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jbmr.233","article-title":"Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996\u20132007","volume":"26","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12020-015-0748-x","article-title":"Duration of anti-resorptive therapy for osteoporosis","volume":"51","year":"2016","journal-title":"Endocrine"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.injury.2017.09.023","article-title":"Location of atypical femoral fracture can be determined by tensile stress distribution influenced by femoral bowing and neck-shaft angle: a CT-based nonlinear finite element analysis model for the assessment of femoral shaft loading stress.","volume":"48","year":"2017","journal-title":"Injury"},{"key":"ref221","first-page":"299","article-title":"Lateral fixation: an alternative surgical approach in the prevention of complete atypical femoral fractures","volume":"28","year":"2017","journal-title":"European Journal of Orthopaedic Surgery and Traumatology"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bone.2016.04.020","article-title":"Strains caused by daily loading might be responsible for delayed healing of an incomplete atypical femoral fracture","volume":"88","year":"2016","journal-title":"Bone"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00402-013-1760-3","article-title":"Atypical forearm fractures associated with long-term use of bisphosphonate","volume":"133","year":"2013","journal-title":"Archives of Orthopaedic and Trauma Surgery"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jbmr.233","article-title":"Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996\u20132007","volume":"26","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12020-015-0748-x","article-title":"Duration of anti-resorptive therapy for osteoporosis","volume":"51","year":"2016","journal-title":"Endocrine"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bone.2016.04.020","article-title":"Strains caused by daily loading might be responsible for delayed healing of an incomplete atypical femoral fracture","volume":"88","year":"2016","journal-title":"Bone"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.injury.2017.09.023","article-title":"Location of atypical femoral fracture can be determined by tensile stress distribution influenced by femoral bowing and neck-shaft angle: a CT-based nonlinear finite element analysis model for the assessment of femoral shaft loading stress.","volume":"48","year":"2017","journal-title":"Injury"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bone.2010.12.033","article-title":"Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features","volume":"48","year":"2011","journal-title":"Bone"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.bone.2012.03.016","article-title":"Five years of anti-resorptive activity after a single dose of zoledronate: results from a randomized double-blind placebo-controlled trial","volume":"50","year":"2012","journal-title":"Bone"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jbmr.3198","article-title":"Effects of denosumab and teriparatide transitions on bone microarchitecture and estimated strength: the DATA-Switch HR-pQCT study","volume":"32","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/jbmr.3221","article-title":"Evaluating atypical features of femur fractures: how change in radiological criteria influenced incidence and demography of atypical femoral fractures in a community setting","volume":"32","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2106\/JBJS.N.00075","article-title":"Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry","volume":"96","year":"2014","journal-title":"Journal of Bone and Joint Surgery American Volume"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref71","first-page":"1","article-title":"Atypical femoral fracture associated with bone-modifying agent for bone metastasis of breast cancer: a report of two cases","volume":"25","year":"2017","journal-title":"Journal of Orthopaedic Surgery"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/jbmr.2818","article-title":"Incidence of atypical femoral fractures in cancer patients: the MD Anderson Cancer Center experience","volume":"31","year":"2016","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/BOR.0000000000000300","article-title":"Determinants of mortality risk following osteoporotic fractures","volume":"28","year":"2016","journal-title":"Current Opinion in Rheumatology"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden","volume":"8","year":"2013","journal-title":"Archives of Osteoporosis"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00198-017-4169-y","article-title":"Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years\u2019 experience in a single center","volume":"28","year":"2017","journal-title":"Osteoporosis International"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/jbmr.3081","article-title":"Responses to treatment with teriparatide in patients with atypical femur fractures previously treated with bisphosphonates","volume":"32","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref751","article-title":"Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicenter, double-blind, double-dummy, randomised controlled trial","year":"2017 Epub","journal-title":"Lancet"},{"key":"ref611","first-page":"299","article-title":"Lateral fixation: an alternative surgical approach in the prevention of complete atypical femoral fractures","volume":"28","year":"2017","journal-title":"European Journal of Orthopaedic Surgery and Traumatology"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1073\/pnas.1704460114","article-title":"Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance","volume":"114","year":"2017","journal-title":"PNAS"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.bone.2012.03.016","article-title":"Five years of anti-resorptive activity after a single dose of zoledronate: results from a randomized double-blind placebo-controlled trial","volume":"50","year":"2012","journal-title":"Bone"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1073\/pnas.1704460114","article-title":"Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance","volume":"114","year":"2017","journal-title":"PNAS"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/RHU.0000000000000170","article-title":"Bisphosphonates and hip and nontraumatic subtrochanteric femoral fractures in the Veterans Health Administration","volume":"20","year":"2014","journal-title":"Journal of Clinical Rheumatology"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00402-017-2764-1","article-title":"Surgical outcomes of intramedullary nailing for diaphyseal atypical femur fractures: is it safe to modify a nail entry in bowed femur?","volume":"137","year":"2017","journal-title":"Archives of Orthopaedic and Trauma Surgery"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six month results of a randomized, double-blind, controlled trial","volume":"60","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/17453674.2014.916488","article-title":"Histology of 8 atypical femoral fractures: remodeling but no healing","volume":"85","year":"2014","journal-title":"Acta Orthopaedica"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","year":"2017","journal-title":"Archives of Osteoporosis"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.1893","article-title":"Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis","volume":"28","year":"2013","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/jbmr.3221","article-title":"Evaluating atypical features of femur fractures: how change in radiological criteria influenced incidence and demography of atypical femoral fractures in a community setting","volume":"32","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","article-title":"The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy","volume":"85","year":"2016","journal-title":"Bone"},{"key":"ref361","article-title":"Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicenter, double-blind, double-dummy, randomised controlled trial","year":"2017 Epub","journal-title":"Lancet"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00198-012-2173-9","article-title":"Atypical fractures do not have a thicker cortex","volume":"23","year":"2012","journal-title":"Osteoporosis International"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/jbmr.3081","article-title":"Responses to treatment with teriparatide in patients with atypical femur fractures previously treated with bisphosphonates","volume":"32","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00198-017-4169-y","article-title":"Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years\u2019 experience in a single center","volume":"28","year":"2017","journal-title":"Osteoporosis International"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00402-017-2764-1","article-title":"Surgical outcomes of intramedullary nailing for diaphyseal atypical femur fractures: is it safe to modify a nail entry in bowed femur?","volume":"137","year":"2017","journal-title":"Archives of Orthopaedic and Trauma Surgery"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","year":"2014","journal-title":"Osteoporosis International"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","year":"2014","journal-title":"Osteoporosis International"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","year":"2016","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/BOR.0000000000000300","article-title":"Determinants of mortality risk following osteoporotic fractures","volume":"28","year":"2016","journal-title":"Current Opinion in Rheumatology"},{"key":"ref741","first-page":"1","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2013 2016","volume":"22","year":"2016","journal-title":"Endocrine Practice"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jbmr.3198","article-title":"Effects of denosumab and teriparatide transitions on bone microarchitecture and estimated strength: the DATA-Switch HR-pQCT study","volume":"32","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.1893","article-title":"Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis","volume":"28","year":"2013","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","article-title":"The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy","volume":"85","year":"2016","journal-title":"Bone"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","year":"2014","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref461","first-page":"1","article-title":"Atypical femoral fracture associated with bone-modifying agent for bone metastasis of breast cancer: a report of two cases","volume":"25","year":"2017","journal-title":"Journal of Orthopaedic Surgery"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/jbmr.2818","article-title":"Incidence of atypical femoral fractures in cancer patients: the MD Anderson Cancer Center experience","volume":"31","year":"2016","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","article-title":"Cost-effective osteoporosis treatment thresholds: the United States perspective","volume":"19","year":"2008","journal-title":"Osteoporosis International"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden","volume":"8","year":"2013","journal-title":"Archives of Osteoporosis"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40618-016-0434-8","article-title":"Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis","volume":"39","year":"2016","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six month results of a randomized, double-blind, controlled trial","volume":"60","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/17453674.2014.916488","article-title":"Histology of 8 atypical femoral fractures: remodeling but no healing","volume":"85","year":"2014","journal-title":"Acta Orthopaedica"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40618-016-0434-8","article-title":"Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis","volume":"39","year":"2016","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00402-013-1760-3","article-title":"Atypical forearm fractures associated with long-term use of bisphosphonate","volume":"133","year":"2013","journal-title":"Archives of Orthopaedic and Trauma Surgery"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bone.2012.10.006","article-title":"Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy","volume":"52","year":"2013","journal-title":"Bone"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/178\/3\/EJE-17-1002.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/EJE-17-1002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:11:35Z","timestamp":1676391095000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/178\/3\/R81\/6655298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":78,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/eje-17-1002","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}